Aisling Capital Management LP Portfolio Holdings
Aisling Capital Management LP
- $286 Million
- Q1 2025
Aisling Capital Management LP has filed its 13F form on May 13, 2025 for Q1 2025 where it was disclosed a total value porftolio of $286 Million distributed in 13 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Bridge Bio Pharma, Inc. with a value of $210M, Verona Pharma PLC with a value of $39.1M, Syndax Pharmaceuticals Inc with a value of $12.6M, Compass Pathways PLC with a value of $10.2M, and Monte Rosa Therapeutics, Inc. with a value of $6.83M.
Examining the 13F form we can see an increase of $13.1M in the current position value, from $273M to 286M.
Aisling Capital Management LP is based out at New York, NY
Below you can find more details about Aisling Capital Management LP portfolio as well as his latest detailed transactions.